These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10136058)

  • 1. Cost-effectiveness ratios: in a league of their own.
    Birch S; Gafni A
    Health Policy; 1994 May; 28(2):133-41. PubMed ID: 10136058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be?
    Birch S; Gafni A
    J Health Econ; 1992 Oct; 11(3):279-96. PubMed ID: 10122540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness league tables: more harm than good?
    Drummond M; Torrance G; Mason J
    Soc Sci Med; 1993 Jul; 37(1):33-40. PubMed ID: 8332922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis in heart disease, Part I: General principles.
    Kupersmith J; Holmes-Rovner M; Hogan A; Rovner D; Gardiner J
    Prog Cardiovasc Dis; 1994; 37(3):161-84. PubMed ID: 7972851
    [No Abstract]   [Full Text] [Related]  

  • 5. On the decision rules of cost-effectiveness analysis.
    Johannesson M; Weinstein MC
    J Health Econ; 1993 Dec; 12(4):459-67. PubMed ID: 10131756
    [No Abstract]   [Full Text] [Related]  

  • 6. Implications of basing health-care resource allocations on cost-utility analysis in the presence of externalities.
    Labelle RJ; Hurley JE
    J Health Econ; 1992 Oct; 11(3):259-77. PubMed ID: 10122539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness league tables: valuable guidance for decision makers?
    Mauskopf J; Rutten F; Schonfeld W
    Pharmacoeconomics; 2003; 21(14):991-1000. PubMed ID: 13129413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness league tables: think of the fans.
    Drummond M; Mason J; Torrance G
    Health Policy; 1995 Mar; 31(3):231-8. PubMed ID: 10142619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-per-QALY league tables: their role in pharmacoeconomic analysis.
    Mason JM
    Pharmacoeconomics; 1994 Jun; 5(6):472-81. PubMed ID: 10147264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QALY league tables: handle with care.
    Gerard K; Mooney G
    Health Econ; 1993 Apr; 2(1):59-64. PubMed ID: 8269048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stochastic league tables: an application to diabetes interventions in the Netherlands.
    Hutubessy RC; Niessen LW; Dijkstra RF; Casparie TF; Rutten FF
    Health Econ; 2005 May; 14(5):445-55. PubMed ID: 15386648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accounting for the missing opportunity costs in incremental cost-outcome analysis.
    Oliver A
    Appl Health Econ Health Policy; 2002; 1(4):191-6. PubMed ID: 14619248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the estimation of cost-effectiveness ratios.
    Johannesson M
    Health Policy; 1995 Mar; 31(3):225-9. PubMed ID: 10142618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of economic evaluation in setting priorities for elective surgery.
    Coast J
    Health Policy; 1993 Aug; 24(3):243-57. PubMed ID: 10171517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic evaluation of health care.
    Haas M; Hall J
    Health Inf Manag; 1998 Dec-1999 Feb; 28(4):169-72. PubMed ID: 10387363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic analysis in dermatology.
    Ellis CN; Reiter KL; Wheeler JR; Fendrick AM
    J Am Acad Dermatol; 2002 Feb; 46(2):271-83. PubMed ID: 11807441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome measurement in economic evaluation.
    Johannesson M; Jönsson B; Karlsson G
    Health Econ; 1996; 5(4):279-96. PubMed ID: 8880165
    [No Abstract]   [Full Text] [Related]  

  • 18. Economic evaluation in health care: is there a role for cost-benefit analysis?
    Johannesson M; Jönsson B
    Health Policy; 1991 Feb; 17(1):1-23. PubMed ID: 10113574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some guidelines on the use of cost effectiveness league tables.
    Mason J; Drummond M; Torrance G
    BMJ; 1993 Feb; 306(6877):570-2. PubMed ID: 8461776
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.